Skip to main content
NewslettersWatchlist

Zoetis Inc Cl A(ZTS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low151.24
Day High153.18
Open:153.01
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
ZOETIS (ZTS) Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Zoetis Inc. for Potential Securities Law Violations
TheNewswire.com
ZOETIS (ZTS): Kaplan Fox & Kilsheimer LLP Investigates Zoetis and Encourages Investors with Losses to Contact the Firm
Motley Fool
How's AT&T Handling Things?
Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?
Barchart
Stocks Give Up Early Gains as Nvidia Weighs on Chip Stocks
Barchart
Stocks Push Higher on Economic Optimism
Barchart
Stocks Climb on Positive Corporate News
Motley Fool
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
The Globe and Mail
Top RRSP investment picks from three veteran advisors
Barchart
Stocks Slump as Hot U.S. CPI Report Dashes Fed Rate Cut Hopes
Motley Fool
Zoetis (ZTS) Q4 2023 Earnings Call Transcript
Baystreet
U.S. Inflation Figures, Retail Sales Due Next Week
Barchart
3 Best Agriculture ETFs to Buy for 2024
Motley Fool
4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
Motley Fool
Zoetis (ZTS) Q3 2023 Earnings Call Transcript
The Globe and Mail
18 U.S. stocks for turbulent times
Motley Fool
4 Top Dividend Growth Stocks of the S&P 500 That Have Major Long-Term Potential for Investors
Motley Fool
Zoetis (ZTS) Q2 2023 Earnings Call Transcript
Barchart
Stock Index Futures Plunge as China Trade Data Disappoints, Moody's Downgrades U.S. Banks
MarketBeat
MarketBeat Week in Review – 07/31 - 08/04
Baystreet
Macro Figures Sparse in Canada During Short Week
MarketBeat
Rising Dividend Make Zoetis a Doggone Winner
Motley Fool
2 Healthcare Stocks That Could Make You Richer
SYNDTGAM
Relentless U.S. stock rally faces Fed test
Motley Fool
2 Dividend Stocks That Doubled Their Payouts in 5 Years
Barchart
Act Fast! These Buy Rated Companies Just Crossed Over Above Their 200-Day SMA!
MarketBeat
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
Motley Fool
History Suggests This S&P 500 Dividend Stock Is Perfect to Buy and Hold Forever
MarketBeat
Bullish or Bearish? Vetting Animal Health Care Stocks
The Globe and Mail
Expanding array of services for pets offers investors chance to get in on sector’s growth
MarketBeat
Zoetis Declares New Dividend, Hinting At Undervaluation
Business Wire
Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs

Profile

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.